Updates in locally advanced pancreatic cancer. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Pancreatic cancer is the 4th leading cancer cause mortality in both men and women. Pancreatic cancer is usually diagnosed in the advanced setting, and only 10-15% of patients present with operable disease. About 25% are locally advanced and unresectable and the rest are metastatic. Studies presented at the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting highlighted both current treatment options and promising novel therapeutic agents and approaches.
Chang
Bryan W
BW
Yale Cancer Center, Yale University School of Medicine, New Haven, CT, USA.
Siccion
Eduardo
E
Saif
Muhammad Wasif
MW
D002277:Carcinoma / Q000473:pathology / Q000628:therapy*; D002641:Chicago; D003226:Congresses as Topic; D018450:Disease Progression; D005260:Female; D006801:Humans; D008297:Male; D008495:Medical Oncology / Q000639:trends; D008954:Models, Biological; D010190:Pancreatic Neoplasms / Q000473:pathology / Q000628:therapy*; D012955:Societies, Medical; D014481:United States